Sensex
78,009.25 profit arw -70.71 (-0.09%)
Nifty
24,366.00 profit arw -29.85 (-0.12%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 15-Aug-2026
Corporate News
15-Aug-2026     00:14

Fredun Pharmaceuticals confirms Rs 111.53 crore preferential issue use, per Care Ratings

Fredun Pharmaceuticals Limited reported no deviation or variation in the utilization of Rs 111.53 crore raised through a preferential issue during the quarter ended June 30, 2026, according to a regulatory filing. The company, in a statement filed with the BSE Limited, acknowledged observations from the Monitoring Agency, Care Ratings Limited, regarding the classification of certain expenditures and reconciliation of unutilized proceeds, but maintained that these did not constitute a deviation from the originally stated objects for which the funds were raised.

INDIAN INDICES

Sensex

78,009.25 -70.71 (-0.09%)

Nifty

24,366.00 -29.85 (-0.12%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,116.86 -279.66(-1.10%)